These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 2499293

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A, Zieleniewska B.
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of anti-factor VIII antibodies.
    Blatt PM, White GC, McMillan CW, Roberts HR.
    Thromb Haemost; 1977 Aug 31; 38(2):514-23. PubMed ID: 579493
    [Abstract] [Full Text] [Related]

  • 9. Use of porcine factor VIII in the management of seventeen patients with factor VIII antibodies.
    Gatti L, Mannucci PM.
    Thromb Haemost; 1984 Jul 29; 51(3):379-84. PubMed ID: 6437005
    [Abstract] [Full Text] [Related]

  • 10. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E, Morfini M, Rocino A, Baudo F, Scaraggi FA, Gringeri A.
    Thromb Haemost; 2001 Oct 29; 86(4):954-8. PubMed ID: 11686352
    [Abstract] [Full Text] [Related]

  • 11. The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial.
    Sjamsoedin LJ, Heijnen L, Mauser-Bunschoten EP, van Geijlswijk JL, van Houwelingen H, van Asten P, Sixma JJ.
    N Engl J Med; 1981 Sep 24; 305(13):717-21. PubMed ID: 6790990
    [Abstract] [Full Text] [Related]

  • 12. Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group.
    Lusher JM, Arkin S, Abildgaard CF, Schwartz RS.
    N Engl J Med; 1993 Feb 18; 328(7):453-9. PubMed ID: 8421474
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of patients with hemophilia A and inhibitors to factor FVIII with cimetidine.
    Ambriz Fernandez R, Quintana Gonzalez S, Martinez Murillo C, Dominguez Garcia V, Rodriguez Moyado H, Collazo Jaloma J.
    Arch Med Res; 1996 Feb 18; 27(1):15-8. PubMed ID: 8867361
    [Abstract] [Full Text] [Related]

  • 17. Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.
    Nilsson IM, Berntorp E, Zettervall O.
    N Engl J Med; 1988 Apr 14; 318(15):947-50. PubMed ID: 3127711
    [Abstract] [Full Text] [Related]

  • 18. Lack of immune response to mouse IgG in hemophilia A patients treated chronically with Monoclate, a monoclonal antibody affinity purified factor VIII preparation.
    Davis HM, Brown SK, Nash DW, Pennetti AM, Salzman PM, Schreiber AB, Haimovich J.
    Thromb Haemost; 1990 Jun 28; 63(3):386-91. PubMed ID: 2119524
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L, Pitlik E.
    Haematologica; 2000 Oct 28; 85(10 Suppl):64-8. PubMed ID: 11187874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.